Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies.

Vera J, Gao LM, Santana A, Matta J, Meléndez E.

Dalton Trans. 2011 Oct 7;40(37):9557-65. doi: 10.1039/c1dt10995b. Epub 2011 Aug 18.

2.

Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.

Vessières A, Top S, Pigeon P, Hillard E, Boubeker L, Spera D, Jaouen G.

J Med Chem. 2005 Jun 16;48(12):3937-40.

PMID:
15943467
3.

Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds.

Zekri O, Hillard EA, Top S, Vessières A, Pigeon P, Plamont MA, Huché M, Boutamine S, McGlinchey MJ, Müller-Bunz H, Jaouen G.

Dalton Trans. 2009 Jun 14;(22):4318-26. doi: 10.1039/b819812h. Epub 2009 Feb 24.

PMID:
19662309
4.

Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.

Saha P, Fortin S, Leblanc V, Parent S, Asselin É, Bérubé G.

Steroids. 2012 Sep;77(11):1113-22. doi: 10.1016/j.steroids.2012.06.004. Epub 2012 Jul 16.

PMID:
22801351
5.

Synthesis and biological evaluation of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core.

Lilienkampf A, Karkola S, Alho-Richmond S, Koskimies P, Johansson N, Huhtinen K, Vihko K, Wähälä K.

J Med Chem. 2009 Nov 12;52(21):6660-71. doi: 10.1021/jm900928k.

PMID:
19824648
6.

The presence of a ferrocenyl unit on an estrogenic molecule is not always sufficient to generate in vitro cytotoxicity.

Vessières A, Spera D, Top S, Misterkiewicz B, Heldt JM, Hillard E, Huché M, Plamont MA, Napolitano E, Fiaschi R, Jaouen G.

ChemMedChem. 2006 Nov;1(11):1275-81.

PMID:
17022106
7.

Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay.

Pérez WI, Soto Y, Ortíz C, Matta J, Meléndez E.

Bioorg Med Chem. 2015 Feb 1;23(3):471-9. doi: 10.1016/j.bmc.2014.12.023. Epub 2014 Dec 19.

8.

Regioselective monoalkylation of 17β-estradiol for the synthesis of cytotoxic estrogens.

Gansbeke KV, Solum EJ, Liekens S, Vik A, Hansen TV.

Steroids. 2017 Aug;124:54-59. doi: 10.1016/j.steroids.2017.06.001. Epub 2017 Jun 15.

PMID:
28624547
9.

Synthesis and biological evaluation of a new vitamin D2 analogue.

Gándara Z, Pérez M, Salomón DG, Ferronato MJ, Fermento ME, Curino AC, Facchinetti MM, Gómez G, Fall Y.

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6276-9. doi: 10.1016/j.bmcl.2012.07.095. Epub 2012 Aug 7.

PMID:
22926068
10.
11.

Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum(II) complex analogs to carboplatin and oxaliplatin. Potential vector complexes to target estrogen-dependent tissues.

Saha P, Descôteaux C, Brasseur K, Fortin S, Leblanc V, Parent S, Asselin E, Bérubé G.

Eur J Med Chem. 2012 Feb;48:385-90. doi: 10.1016/j.ejmech.2011.12.017. Epub 2011 Dec 17.

PMID:
22209414
12.

Water soluble molybdenocene complexes: synthesis, cytotoxic activity and binding studies to ubiquitin by fluorescence spectroscopy, circular dichroism and molecular modeling.

Narváez-Pita X, Ortega-Zuniga C, Acevedo-Morantes CY, Pastrana B, Olivero-Verbel J, Maldonado-Rojas W, Ramírez-Vick JE, Meléndez E.

J Inorg Biochem. 2014 Mar;132:77-91. doi: 10.1016/j.jinorgbio.2013.10.014. Epub 2013 Oct 29.

PMID:
24287102
13.

Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator--a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons.

Zhao L, Jin C, Mao Z, Gopinathan MB, Rehder K, Brinton RD.

J Med Chem. 2007 Sep 6;50(18):4471-81. Epub 2007 Aug 14.

PMID:
17696335
14.

Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.

Perron V, Rabouin D, Asselin E, Parent S, C-Gaudreault R, Bérubé G.

Bioorg Chem. 2005 Feb;33(1):1-15.

PMID:
15668178
15.

Organometallic cyclic polyphenols derived from 1,2-(alpha-keto tri or tetra methylene) ferrocene show strong antiproliferative activity on hormone-independent breast cancer cells.

Plazuk D, Top S, Vessières A, Plamont MA, Huché M, Zakrzewski J, Makal A, Woźniak K, Jaouen G.

Dalton Trans. 2010 Aug 28;39(32):7444-50. doi: 10.1039/c0dt00169d. Epub 2010 Jul 8.

PMID:
20614088
17.

Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.

Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, Wang G.

J Med Chem. 2010 Aug 26;53(16):6153-63. doi: 10.1021/jm100610w.

18.

Ferrocenylselenoamides: synthesis, characterization and cytotoxic properties.

Gutiérrez-Hernández AI, López-Cortés JG, Ortega-Alfaro MC, Ramírez-Apan MT, Cázares-Marinero Jde J, Toscano RA.

J Med Chem. 2012 May 24;55(10):4652-63. doi: 10.1021/jm300150t. Epub 2012 May 1.

PMID:
22524555
19.

Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling.

Nehybova T, Smarda J, Daniel L, Brezovsky J, Benes P.

J Steroid Biochem Mol Biol. 2015 Aug;152:76-83. doi: 10.1016/j.jsbmb.2015.04.019. Epub 2015 Apr 28.

PMID:
25934092
20.

Identification of novel estrogen receptor (ER) agonists that have additional and complementary anti-cancer activities via ER-independent mechanism.

Kim T, Kim HI, An JY, Lee J, Lee NR, Heo J, Kim JE, Yu J, Lee YS, Inn KS, Kim NJ.

Bioorg Med Chem Lett. 2016 Apr 1;26(7):1844-8. doi: 10.1016/j.bmcl.2016.01.089. Epub 2016 Feb 13.

PMID:
26905830

Supplemental Content

Support Center